Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001511866 | SCV001719179 | benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001712918 | SCV001939438 | likely benign | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002421164 | SCV002718504 | benign | Inborn genetic diseases | 2017-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003931055 | SCV004739094 | likely benign | CDKL5-related condition | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001712918 | SCV001978071 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001712918 | SCV001980429 | likely benign | not provided | no assertion criteria provided | clinical testing |